Aridis Pharma seeks $10M for oral-form drugs and vaccines
March 10, 2008 | David P. Hamilton
See our story about this San Jose, Calif., biotech in Friday’s briefing at VentureBeat LifeScience.
Next Story: BrainCells raises $30M for neuroregeneration drugs
Previous Story: Neurosurgical device maker Nfocus Neuro acquires StarFire Medical
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.












